Penbrook Management LLC - EXAGEN INC ownership

EXAGEN INC's ticker is XGN and the CUSIP is 30068X103. A total of 41 filers reported holding EXAGEN INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Penbrook Management LLC ownership history of EXAGEN INC
ValueSharesWeighting
Q3 2023$177,652
-17.2%
73,410
-0.8%
0.13%
-16.7%
Q2 2023$214,629
+19.3%
74,0100.0%0.16%
+13.0%
Q1 2023$179,844
+1.2%
74,0100.0%0.14%
-8.6%
Q4 2022$177,624
-24.7%
74,010
-14.9%
0.15%
-25.6%
Q3 2022$236,000
-53.4%
87,000
-1.2%
0.20%
-49.1%
Q2 2022$506,000
-28.8%
88,100
-0.6%
0.40%
-13.4%
Q1 2022$711,000
-31.0%
88,6000.0%0.46%
-25.8%
Q4 2021$1,030,000
-13.7%
88,600
+1.0%
0.62%
-16.2%
Q3 2021$1,193,00087,7500.74%
Other shareholders
EXAGEN INC shareholders Q3 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,203,491$2,912,4480.97%
PERKINS CAPITAL MANAGEMENT INC 263,905$6390.63%
COWEN AND COMPANY, LLC 842,376$2,063,8210.14%
Penbrook Management LLC 73,410$177,6520.13%
RTW INVESTMENTS, LP 1,492,432$3,611,6850.08%
Nantahala Capital Management 106,769$258,3810.02%
WASATCH ADVISORS LP 856,273$2,097,8690.01%
SILVERCREST ASSET MANAGEMENT GROUP LLC 544,877$1,318,6020.01%
First Bank & Trust 14,375$34,7880.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 40,800$99,9600.00%
View complete list of EXAGEN INC shareholders